Therapeutic Class Tables
- Introduction to Clinical Criteria Sort By: Table Number | Table Name
- Table 1 : Immune Globulins
- Table 2 : Hormones - Gonadotropin-Releasing Hormone Analogs
- Table 3 : Gastrointestinal Drugs - Histamine H2 Antagonists, Proton Pump Inhibitors, and Miscellaneous Gastroesophageal Reflux Agents
- Table 4 : Hematologic Agents - Hematopoietic and Miscellaneous Hematologic Agents
- Table 5 : Immunological Agents
- Table 6 : Nutrients, Vitamins, and Vitamin Analogs
- Table 7 : Muscle Relaxants - Skeletal
- Table 8 : Opioids and Analgesics
- Table 9 : Growth Hormones and Increlex
- Table 10 : Dermatologic Agents - Acne and Rosacea
- Table 11 : Nonsteroidal Anti-Inflammatory Drugs
- Table 12 : Antihistamines
- Table 13 : Lipid-Lowering Agents
- Table 14 : Headache Therapy
- Table 15 : Hypnotics
- Table 16 : Corticosteroids - Topical
- Table 17 : Antidepressants
- Table 18 : Cardiovascular Agents
- Table 19 : Benign Prostatic Hyperplasia (BPH) Agents
- Table 20 : Anticonvulsants
- Table 21 : Cystic Fibrosis Agents
- Table 22 : Acromegaly, Carcinoid Syndrome, and Cushing's Syndrome Agents
- Table 23 : Respiratory Agents - Inhaled
- Table 24 : Antipsychotics
- Table 25 : Corticosteroids - Intranasal
- Table 26 : Antidiabetic Agents
- Table 27 : Antiemetics, Appetite Stimulants, and Anabolics
- Table 28 : Antifungal Agents - Topical
- Table 29 : Anti-Allergy and Anti-Inflammatory Agents - Ophthalmic
- Table 30 : Neuromuscular Blocker Agents
- Table 31 : Cerebral Stimulants and Miscellaneous Agents
- Table 32 : Serums, Toxoids, and Vaccines
- Table 33 : Inflammatory Bowel Disease Agents
- Table 34 : Antibiotics - Ophthalmic
- Table 35 : Antibiotics and Anti-Infectives - Oral and Inhaled
- Table 36 : Drug and Alcohol Cessation Agents
- Table 37 : Respiratory Syncytial Virus (RSV) Prophylaxis Agents
- Table 38 : Antiretroviral/HIV Therapy
- Table 39 : Influenza Prophylaxis and Treatment Agents
- Table 40 : Respiratory Agents - Oral
- Table 41 : Antibiotics - Topical
- Table 42 : Immune Suppressants - Topical
- Table 43 : Pulmonary Hypertension Agents
- Table 44 : Hepatitis Antiviral Agents
- Table 45 : Beta Thalassemia, Myelodysplastic Syndrome, and Sickle Cell Disease Agents
- Table 46 : Urinary Dysfunction Agents
- Table 47 : Antifungal Agents - Oral and Injectable
- Table 48 : Antiparkinsonian Agents
- Table 49 : Osteoporosis and Bone Metabolism Agents
- Table 50 : Narcolepsy and Miscellaneous Sleep Disorder Therapy Agents
- Table 51 : Antiglaucoma Agents - Ophthalmic
- Table 52 : Multiple Sclerosis Agents
- Table 53 : Otic Agents
- Table 54 : Pediculicides and Scabicides
- Table 55 : Androgens
- Table 56 : Alzheimer’s Agents
- Table 57 : Oncology Agents
- Table 58 : Anticoagulants and Antiplatelet Agents
- Table 59 : Anesthetics - Topical
- Table 60 : Hereditary Angioedema Agents
- Table 61 : Gastrointestinal Drugs – Antidiarrheals, Constipation, and Miscellaneous Gastrointestinal Agents
- Table 62 : Gout Agents
- Table 63 : Dermatologic Agents - Topical Chemotherapy, Genital Wart Treatment, and Miscellaneous Dermatologic Agents
- Table 64 : Asthma/Allergy Monoclonal Antibodies
- Table 65 : Enzyme and Metabolic Disorder Therapies
- Table 66 : Antibiotics and Anti-Infectives – Injectable
- Table 67 : Antiviral Agents
- Table 68 : Thrombocytopenic Agents
- Table 69 : Barbiturates, Benzodiazepines, and Miscellaneous Antianxiety Agents
- Table 70 : Progesterone Agents
- Table 71 : Pediatric Behavioral Health
- Table 72 : Agents not Otherwise Classified
- Table 73 : Iron Agents and Chelators
- Table 74 : Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors
- Table 75 : T-Cell Immunotherapies
- Table 76 : Neuromuscular Agents – Duchenne Muscular Dystrophy and Spinal Muscular Atrophy
- Table 77 : Hyaluronan Injections
- Table 78 : Diabetes Medical Supplies and Emergency Treatments
- Table 79 : Pharmaceutical Compounds
- Table 80 : Anti-Hemophilia Agents
- Table 81 : Anti-Obesity Agents